Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
2
×
boston
2
×
boston blog main
boston top stories
harvard pilgrim health care
institute for clinical and economic review
life sciences
2
×
national blog main
national top stories
new york blog main
2
×
akcea therapeutics
amy schulman
andreas klein
anna greka
barry greene
car-t
caron jacobson
cigall kadoch
craig mello
dan ollendorf
drugs
european medicines agency
events
fda
foghorn therapeutics
gene therapy
goldfinch biopharma
hereditary transthyretin amyloidosis
inotersen
luxturna
michael sherman
national
new york top stories
onpattro
patisiran
people
pfizer
rna interference
san diego blog main
san diego top stories
What
gene
2
×
interference
2
×
rna
alnylam
approves
aren’t
car
cells
cutting
drug
edge
ema
employ
europe
experiments
fda
follows
harmful
hits
hot
launch
make
market
medicine
medicines
method
mute
payers
photos
protein
real
rnai
science
soon
therapy
they’re
t’s
uses
vs
way
Language
Current search:
gene
×
boston
×
" new york blog main "
×
" life sciences "
×
interference
×
" alnylam pharmaceuticals "
×
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”